(Q80298403)
Statements
Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function (English)
C Bedini
F Nasorri
G Girolomoni
O de Pità